Javier Mancilla-Ramirez

Dr. Javier Mancilla-Ramirez

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Fetal Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
EHEdgar Hernandez-Andrade
Edgar Hernandez-Andrade
JBJesus Andres Benavides-Serralde
Jesus Andres Benavides-Serralde
RCRogelio Cruz-Martinez
Rogelio Cruz-Martinez
AWAlec Welsh
Alec Welsh
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
Structural evaluation of the fetal heart is well established. Functional evaluation using pulsed-wave Doppler may also be performed. E/A ratios express the relationship between the maximal velocities of the E and A waveforms of ventricular filling. In normal fetuses, E/A ratios are usually <1 but show a constant increment during gestation, mainly related to the increment of the E wave. In intrauterine growth restriction (IUGR) fetuses, E/A ratios are lower compared to values in normally grown fetuses at the same gestational age. Cardiac outflows provide information on the time-velocity integral that, combined with the vessel area, allows calculation of the left and right cardiac outputs. In normal fetuses there is a predominance of the right ventricle (55–60%) in contributing to the combined cardiac output. In IUGR fetuses this predominance shifts to the left ventricle in order to increase the flow to the upper part of the fetal body and brain. The myocardial performance index (MPI) also provides information on systolic and diastolic cardiac function. The MPI is an early and consistent marker of cardiac dysfunction which becomes altered in early stages of chronic hypoxia or in cases with cardiac overload such as in twin-to-twin transfusion syndrome.

1 October 1991 in Brain Research
Verified
Journal Article
Closed access
CDCharles A. Dinarello
Charles A. Dinarello
JCJoseph G. Cannon
Joseph G. Cannon
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
IBIsis Bishai
Isis Bishai
JLJodi Lees
Jodi Lees
FCFlavio Coceani
Flavio Coceani

1 April 2014 in Pediatrics
Verified
Journal Article
Closed access
PDF file
PGPedro Gutierrez-Castrellon
Pedro Gutierrez-Castrellon
Gabriel López-VelázquezGabriel López-Velázquez
Gabriel López-Velázquez
LDLuisa Diaz-Garcia
Luisa Diaz-Garcia
CJCarlos Jimenez-Gutierrez
Carlos Jimenez-Gutierrez
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
MPMinerva Parra
Minerva Parra
OBJECTIVES: To evaluate whether daily administration of Lactobacillus reuteri DSM 17938 reduces the frequency and duration of diarrheal episodes and other health outcomes in day school children in Mexico. METHODS: Healthy children (born at term, aged 6–36 months) attending day care centers were enrolled in this randomized, double-blind, placebo-controlled trial. They received L reuteri DSM 17938 (dose 108 colony-forming unit; n = 168) or identical placebo (n = 168) by mouth, daily for 3 months, after which they were followed-up after a further 3 months without supplementation. RESULTS: Data from all children were included in the final analysis. L reuteri DSM 17938 significantly reduced the frequency and duration of episodes of diarrhea and respiratory tract infection at both 3 and 6 months (P < .05). Additionally, the number of doctor visits, antibiotic use, absenteeism from day school and parental absenteeism from work were significantly reduced in the L reuteri group (P < .05). A cost-benefit analysis revealed significant reductions in costs in the L reuteri-treated children. No adverse events related to the study product were reported. CONCLUSIONS: In healthy children attending day care centers, daily administration of L reuteri DSM 17938 had a significant effect in reducing episodes and duration of diarrhea and respiratory tract infection, with consequent cost savings for the community.

1 January 2006 in Archives of Medical Research
Verified
Journal Article
Closed access
PGPilar Garcia-Roca
Pilar Garcia-Roca
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
ASAraceli Santos-Segura
Araceli Santos-Segura
MFMarisol Fernández-Avilés
Marisol Fernández-Avilés
ECErnesto Calderon-Jaimes
Ernesto Calderon-Jaimes

1 January 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ESEnrique Segura-Cervantes
Enrique Segura-Cervantes
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
JGJorge González-Canudas
Jorge González-Canudas
EAErika Alba
Erika Alba
RSRené Santillán-Ballesteros
René Santillán-Ballesteros
NGNorma Galindo-Sevilla
Norma Galindo-Sevilla
The response of the adaptive immune system is usually less intense in premature neonates than term neonates. The primary objective of this study was to determine whether immunological parameters vary between preterm (PT) neonates (≥32 weeks of gestational age) and very preterm (VPT) neonates (<32 weeks of gestational age). A cross-sectional study was designed to prospectively follow PT and VPT neonates at risk of developing sepsis. Plasma concentrations of IFN-γ, TNF-α, IL-6, IL-4, and IL-10 were detected using flow cytometry. C-reactive protein (C-RP) and the complex SC5b-9 were detected in the plasma using commercial kits. A total of 83 patients were included. The laboratory results and clinical histories showed that 26 patients had sepsis; 14 were VPT, and 12 were PT. The levels of C-RP, SC5b-9 (innate immune response mediators), and IL-10 or IL-4 (anti-inflammatory cytokines) were elevated during sepsis in both groups. IFN-γ, TNF-α, and IL-6 (proinflammatory cytokines) were differentially elevated only in PT neonates. The VPT neonates with sepsis presented increases in C-RP, SC5b-9, and anti-inflammatory cytokines but not in proinflammatory cytokines, whereas PT neonates showed increases in all studied mediators of inflammation.

1 October 2012 in Vector-Borne and Zoonotic Diseases
Verified
Journal Article
Open access
LQLaura Quiñonez-Díaz
Laura Quiñonez-Díaz
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
Miroslava Avila-GarcíaMiroslava Avila-García
Miroslava Avila-García
JOJuana Ortiz-Avalos
Juana Ortiz-Avalos
ABAngélica Berron
Angélica Berron
NGNorma Galindo-Sevilla
Norma Galindo-Sevilla
Dermal species of Leishmania have a relatively broad temperature range for optimal growth in vitro , with temperature differences accompanied by a form change. This suggests that when the host is living in moderate temperatures (22°C), infection may proceed at temperatures lower than those that occur in tropical regions (32°C), and a different clinical expression of the disease due to a different parasitic form may result. The aim of this study was to investigate the effect of environmental temperature on the clinical expression of the disease. BALB/C mice infected with Leishmania mexicana were housed at 32°±2°C or 22°±1°C, and assessed for the development of inflammation and the presence of parasites in organs using PCR and immunohistology. The clinical expression of leishmaniasis at 32°C included inflammation at the site of inoculation with swelling of the nose and tail, whereas at 22°C, up to 50% of the infected mice developed dry exfoliative dermatitis with alopecia on the dorsum. In both cases, parasite colonization was confirmed in the skin, with parasites at more external locations at 22°C. Parasite visceralization was confirmed in all internal organs and glands in both cases based on PCR and immunohistology. In conclusion, the clinical expression of diffuse leishmaniasis by Leishmania mexicana in laboratory mice is modified by temperature, from nodular inflammation at 32°C, to dry exfoliative dermatitis and alopecia at 22°C, with parasite visceralization in both cases.